Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humans

Journal of Physiology

Volumn 590, Issue 11, 2012, Pages 2801-2809

  Peltonen, Garrett L ^a   Scalzo, Rebecca L ^a   Schweder, Melani M ^a   Larson, Dennis G ^b   Luckasen, Gary J ^b   Irwin, David ^c   Hamilton, Karyn L ^a   Schroeder, Thies ^d   Bell, Christopher ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

^b Poudre Valley Health System Medical Center of the Rockies   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; GLUCOSE; INSULIN; NORADRENALIN; OXYHEMOGLOBIN;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOXIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC BLOCKING;

ADULT; ANOXIA; BLOOD GLUCOSE; CLONIDINE; HUMANS; INSULIN RESISTANCE; MALE; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; YOUNG ADULT;

EID: 84861665788     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.227090     Document Type: Article

References (38)

1. Bell C (2011). Pigment epithelium-derived factor: a not so sympathetic regulator of insulin resistance? Exerc Sport Sci Rev 39, 187-190.
2. Bloomgarden ZT (2006). Measures of insulin sensitivity. Clin Lab Med 26, 611-633.
3. 1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91, 623-631.
4. Calbet JA (2003). Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol 551, 379-386.
5. Chai W, Liu J, Jahn LA, Fowler DE, Barrett EJ & Liu Z (2011). Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. Diabetes Care 34, 1634-1638.
6. de Mol P, de Vries ST, de Koning EJ, Gans RO, Tack CJ & Bilo HJ (2011). Increased insulin requirements during exercise at very high altitude in type 1 diabetes. Diabetes Care 34, 591-595.
7. DeFronzo RA, Tobin JD & Andres R (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab 237, E214-223.
8. Furlan R, Ardizzone S, Palazzolo L, Rimoldi A, Perego F, Barbic F, Bevilacqua M, Vago L, Bianchi Porro G & Malliani A (2006). Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am J Physiol Regul Integr Comp Physiol 290, R224-232.
9. Gay PC (2010). Sleep and sleep-disordered breathing in the hospitalized patient. Respir Care 55, 1240-1254.
10. Hansen J & Sander M (2003). Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 546, 921-929.
11. Heindl S, Lehnert M, Criee CP, Hasenfuss G & Andreas S (2001). Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 164, 597-601.
12. Hunt DG & Ivy JL (2002). Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 93, 1638-1643.
13. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY & O'Donnell CP (2007). Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175, 851-857.
14. Karlsson AK (1999). Insulin resistance and sympathetic function in high spinal cord injury. Spinal Cord 37, 494-500.
15. Laaban JP, Daenen S, Leger D, Pascal S, Bayon V, Slama G & Elgrably F (2009). Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 35, 372-377.
16. Lambert EA & Lambert GW (2011). Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep 13, 244-248.
17. Landsberg L (1990). Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A 12, 817-830.
18. Larsen JJ, Hansen JM, Olsen NV, Galbo H & Dela F (1997). The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504, 241-249.
19. Muzi M, Goff DR, Kampine JP, Roerig DL & Ebert TJ (1992). Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology 77, 864-871.
20. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME & Somers VK (1998). Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772-776.
21. Newsom SA, Richards JC, Johnson TK, Kuzma JN, Lonac MC, Paxton RJ, Rynn GM, Voyles WF & Bell C (2010). Short-term sympathoadrenal inhibition augments the thermogenic response to β-adrenergic receptor stimulation. J Endocrinol 206, 307-315.
22. Nonogaki K (2000). New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43, 533-549.
23. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL & Peters A (2004). Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169, 1231-1237.
24. Park SH, Kim JY, Lee JH & Park HY (2011). Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome. Clin Chim Acta 412, 435-440.
25. Prabhakar NR & Kumar GK (2010). Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir Physiol Neurobiol 174, 156-161.
26. Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W & Thamprasit A (2004). Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. J Clin Endocrinol Metab 89, 6266-6270.
27. Raz I, Katz A & Spencer MK (1991). Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol Endocrinol Metab 260, E430-435.
28. Richards JC, Johnson TK, Kuzma JN, Lonac MC, Schweder MM, Voyles WF & Bell C (2010a). Short-term sprint interval training increases insulin sensitivity in healthy adults but does not affect the thermogenic response to β-adrenergic stimulation. J Physiol 588, 2961-2972.
29. Richards JC, Lonac MC, Johnson TK, Schweder MM & Bell C (2010b). Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans. Med Sci Sports Exerc 42, 739-744.
30. Schober AK, Neurath MF & Harsch IA (2011). Prevalence of sleep apnoea in diabetic patients. Clin Respir J 5, 165-172.
31. Schwartz RS, Jaeger LF & Veith RC (1990a). The thermic effect of feeding in older men: the importance of the sympathetic nervous system. Metabolism 39, 733-737.
32. Schwartz RS, Jaeger LF, Veith RC & Lakshminarayan S (1990b). The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men. Int J Obes 14, 1-11.
33. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, Khor VK, Ahima RS & Grinspoon SK (2011). TNF-α antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab 96, E146-E150.
34. Vicini P, Avogaro A, Spilker ME, Gallo A & Cobelli C (2002). Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach. Am J Physiol Endocrinol Metab 283, E78-E84.
35. Wehrwein EA, Basu R, Basu A, Curry TB, Rizza RA & Joyner MJ (2010). Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies? J Physiol 588, 4593-4601.
36. Wolk R & Somers VK (2007). Sleep and the metabolic syndrome. Exp Physiol 92, 67-78.
37. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P & Kadowaki T (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946.
38. Zoccal DB & Machado BH (2011). Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension. Curr Hypertens Rep 13, 229-236.